← BIOGEN INC.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Current assets: | |||||||||||
| Cash and Cash Equivalents, at Carrying Value | $2.3b | $1.6b | $1.2b | $2.9b | — | — | — | — | — | — | |
| Inventory, Net | $1.0b | $902.7m | $929.9m | $804.2m | $1.1b | $1.4b | $1.3b | $2.5b | $2.5b | $2.2b | |
| Assets, Current | $8.7b | $7.9b | $7.6b | $8.4b | $6.9b | $7.9b | $9.8b | $6.9b | $7.5b | $9.0b | |
| Property, Plant and Equipment, Net | $2.5b | $3.2b | $3.6b | $3.2b | $3.4b | $3.4b | $3.3b | $3.3b | $3.2b | $3.1b | |
| Goodwill | $3.7b | $4.6b | $5.7b | $5.8b | $5.8b | $5.8b | $5.7b | $6.2b | $6.5b | $6.5b | |
| Intangible Assets, Net (Excluding Goodwill) | $3.8b | $3.9b | $3.1b | $3.5b | $3.1b | $2.2b | $1.9b | $8.4b | $9.7b | $9.2b | |
| Operating Lease, Right-of-Use Asset | — | — | — | $427.0m | $433.3m | $375.4m | $403.9m | $420.0m | $356.4m | $265.4m | |
| Other Assets, Noncurrent | $1.3b | $1.0b | $1.7b | $1.3b | $2.9b | $1.9b | $1.5b | $745.0m | $560.5m | $750.6m | |
| Additional Financial Items | |||||||||||
| Accounts Receivable, after Allowance for Credit Loss, Current | $1.4b | $1.8b | $2.0b | $1.9b | $1.9b | $1.5b | $1.7b | $1.7b | $1.4b | $1.3b | |
| Assets | $22.9b | $23.7b | $25.3b | $27.2b | $24.6b | $23.9b | $24.6b | $26.8b | $28.0b | $29.4b | |
| LIABILITIES AND EQUITY | |||||||||||
| Current liabilities: | |||||||||||
| Operating Lease, Liability, Current | — | — | — | — | — | — | $97.2m | $90.3m | $86.4m | $80.4m | |
| Accounts Payable, Current | $279.8m | $395.5m | $370.5m | $530.8m | $454.9m | $589.2m | $491.5m | $403.3m | $424.2m | $432.0m | |
| Operating Lease, Liability, Noncurrent | — | — | — | $412.7m | $402.0m | $330.4m | $333.0m | $400.0m | $334.5m | $290.4m | |
| Liabilities, Current | $3.4b | $3.4b | $3.3b | $4.9b | $3.7b | $4.3b | $3.3b | $3.4b | $5.5b | $3.3b | |
| Deferred Income Tax Liabilities, Net | — | — | — | — | $1.0b | $694.5m | $334.7m | $641.8m | $190.5m | $507.6m | |
| Other Liabilities, Noncurrent | $722.5m | $1.6b | $1.4b | $1.3b | $1.3b | $1.3b | $944.2m | $781.1m | $732.3m | $748.5m | |
| Long-term Debt | $6.5b | $5.9b | $5.9b | $4.5b | $7.4b | $6.3b | $6.3b | $6.9b | $6.3b | $6.3b | |
| Deferred Tax Liabilities, Net | $490.1m | $358.6m | $2.3b | $3.5b | $1.9b | $1.8b | $1.7b | $2.6b | $2.8b | $2.5b | |
| Liabilities | $10.7b | $11.1b | $12.3b | $13.9b | $13.9b | $12.9b | $11.2b | $12.0b | $11.3b | $11.2b | |
| Stockholders’ equity: | |||||||||||
| Preferred Stock, Value, Issued | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Common Stock, Value, Issued | $100k | $100k | $100k | $100k | $100k | $100k | $100k | $100k | $100k | $100k | |
| Additional Paid in Capital | $0 | $97.8m | $0 | $0 | $0 | $68.2m | $73.3m | $302.5m | $569.4m | $863.1m | |
| Retained Earnings (Accumulated Deficit) | $15.1b | $15.8b | $16.3b | $16.5b | $14.0b | $13.9b | $16.5b | $17.6b | $19.3b | $20.6b | |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | ($319.9m) | ($318.4m) | ($240.4m) | ($135.2m) | ($299.0m) | ($106.7m) | ($164.9m) | ($153.7m) | ($136.2m) | ($182.0m) | |
| Stockholders' Equity Attributable to Parent | $12.1b | $12.6b | $13.0b | $13.3b | $10.7b | $10.9b | $13.4b | $14.8b | — | — | |
| Stockholders' Equity Attributable to Noncontrolling Interest | ($11.5m) | ($14.7m) | ($8.0m) | ($4.1m) | ($14.2m) | $63.5m | ($9.5m) | $0 | — | — | |
| Liabilities and Equity | $22.9b | $23.7b | $25.3b | $27.2b | $24.6b | $23.9b | $24.6b | $26.8b | $28.0b | $29.4b |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.